Sterkem Pharma Private Limited, a active private limited company, was established on 28 March 2002 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2002PTC135324. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Employing 119 professional, Its leadership includes Heena Mayank Patel (Director), Ajit Naginbhai Desai (Director), Sheela Harish Merchant (Director). Past directors included Uday Kishorbhai Amin, Jayantilal Lallubhai Patel, Manit Mayank Patel. It holds ₹1.10 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S/3, Khira Indl Estate, B M Bhargoankar Road,, Santacruz West,, Mumbai, Maharashtra, 400054.
U51909MH2002PTC135324
135324
28 March 2002
₹0.20 M
₹0.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sterkem Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Heena Mayank Patel | Director | 01 Apr 2015 | Current |
| Ajit Naginbhai Desai | Director | 28 Mar 2002 | Current |
| Sheela Harish Merchant | Director | 01 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2012 | Past |
| Pramod Abcsdd | Director | 01 Jul 2015 | Past |
| Pramod Abcsdd | Director | 21 May 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sterkem Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.48% increase. The company also saw a substantial fall in profitability, with a 24.85% decrease in profit. The company's net worth Soared by an impressive increase of 51.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sterkem Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,100,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2023 | Hdfc Bank Limited | ₹1.10 M | Open |
Explore comprehensive loan charge details -
Sterkem Pharma has a workforce of 119 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sterkem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterkem Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sterkem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Sheela Harish Merchant was appointed as a Director was appointed as a Director on 01 Sep 2025 & has been associated with this company since 3 months 5 days . was completed.
Sterkem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.10 M with Charge ID 100862315 was registered on 13 Nov 2023. was completed.
Heena Mayank Patel was appointed as a Director was appointed as a Director on 01 Apr 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
Progress on Ajit Naginbhai Desai was appointed as a Director was appointed as a Director on 28 Mar 2002 & has been associated with this company since 23 years 8 months . was documented.
The CIN of Sterkem Pharma Private Limited is U51909MH2002PTC135324.
Sterkem Pharma Private Limited is headquartered at S/3, Khira Indl Estate, B M Bhargoankar Road,, Santacruz West,, Mumbai, Maharashtra, 400054.
Sterkem Pharma Private Limited was incorporated on 28 March 2002.
The current directors of Sterkem Pharma Private Limited are
The primary industry of Sterkem Pharma Private Limited is Trade.
Sterkem Pharma Private Limited is unlisted.
The authorized capital of Sterkem Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
The compliance status of Sterkem Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX